One of the public health concerns about prescription opioids, including for pain, is diversion, but injectables can help avoid those concerns. Last spring Hikma released a new generic buprenorphine injectable product indicated for pain, a generic version of Indivior’s Buprenex. For more information, go to … [Read more...] about Generic Buprenex
To Mallinckrodt: Thank you from AT Forum
We all want to thank Mallinckrodt for almost 30 years of support. This wonderful company provided support from the beginning of the newsletter, which first came out in 1992 during the dark days for methadone and opioid treatment programs. At the time, the late Stewart B. Leavitt, Ph.D., with funding what was then called Mallinckrodt Specialty Chemicals Company, helped provide … [Read more...] about To Mallinckrodt: Thank you from AT Forum
‘I am Alone’: Opioid Relapses on the Rise as COVID-19 Interrupts Drug Addiction Recovery in Dallas
North Texas addiction treatment centers are working hard to keep facilities open during the COVID-19 pandemic. The goal: to give some of the highest-risk patients access to medications that treat opioid addiction. The opioid epidemic hasn’t been supplanted by the pandemic. Rather, the pandemic has worsened an already existing crisis. In the Dallas area, the pandemic is … [Read more...] about ‘I am Alone’: Opioid Relapses on the Rise as COVID-19 Interrupts Drug Addiction Recovery in Dallas
Methadone Patients’ Data Poised to Be Entered Into PDMPs
Starting August 14, methadone patients face the very real possibility that their long-protected privacy will be gone. The Substance Abuse and Mental Health Service Administration (SAMHSA) final rule on the regulation 42 CFR Part 2 allows opioid treatment programs (OTPs, known as methadone clinics) to put patient information into prescription drug monitoring programs (PDMPs). … [Read more...] about Methadone Patients’ Data Poised to Be Entered Into PDMPs
Federal Funds to Fight Opioid Crisis Don’t Meet Demand
Current federal funding levels to combat the opioid crisis do not meet the alarming demand brought on by the COVID-19 pandemic, according to a new report. The Bipartisan Policy Center on Wednesday released a report that found federal opioid funding grew only 3.2% in fiscal year 2019, for a total of $7.6 billion. Three-quarters of that funding went toward … [Read more...] about Federal Funds to Fight Opioid Crisis Don’t Meet Demand
